News and Upcoming events - Providence

Upcoming Events

Press

Providence Medical Technology announces FDA Clearance of the CAVUX® Facet Fixation System for the treatment of Cervical Pseudarthrosis

Providence Medical Technology, Inc., a medical device innovator focused on improving surgical outcomes for high-risk spine surgery patients, announced that the U.S. Food and Drug Administration (FDA) has cleared its CAVUX® Facet Fixation System (FFS) for a new indication. The Facet Fixation System (FFS) is a novel integrated cage and screw system that is implanted bilaterally in the facet joints to provide stabilization until fusion occurs. View Release

Read More
Providence Medical Technology Announces First Patient Enrollment in the "FUSE" IDE Clinical Study

Providence Medical Technology, Inc., a medical device innovator focused on improving surgical outcomes of the cervical spine, announced initiation of enrollment in a human clinical Investigational Device Exemption (IDE) study evaluating the safety and effectiveness of its Posterior Cervical Stabilization System (PCSS) in patients with 3-level degenerative disc disease. The first case was performed by Dr. Pierce Nunley, MD, Director of the Spine Institute of Louisiana in Shreveport, Louisiana.

Read More
Providence Medical Technology Secures $25 Million In Equity Financing

Providence Medical Technology, Inc., an innovator in tissue-sparing surgical equipment and implants for cervical spine fusion surgery, today announced the closing of $25 million in new equity financing. The proceeds of the financing will be used to accelerate commercial expansion and clinical development of its DTRAX® line of cervical fusion instruments designed to help patients suffering from advanced cervical spine conditions.

Providence Medical Technology Announces FDA 510(k) Clearance for DTRAX® Spinal System

Providence Medical Technology, Inc. today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its DTRAX® Spinal System to be specifically indicated for use in posterior cervical fusion in patients with cervical degenerative disc disease.

Providence Medical Technology Announces Appointment of US Sales Executive and Publication of Two Additional Clinical Studies

Jeremy Laynor joins Providence as Vice President of US sales. Two new studies published in the Journal of Craniovertebral Junction and Spine further demonstrate the clinical benefits of Providence's unique cervical fusion technology.

Providence Medical Technology Expands Offering of Posterior Cervical Fusion Solutions

Announces FDA Regulatory Clearance for ALLY® Posterior Fixation System.

Providence Medical Technology Announces Publication of Two New Studies Supporting Tissue-Sparing Posterior Cervical Fusion

Multiple independent studies demonstrate the results of Providence's tissue-sparing posterior cervical fusion technology.

Providence Medical Technology Secures New Financing of $10.5 Million From Bridge Bank

Proceeds to further commercialize and expand distribution of cervical fusion technology.

Providence Medical Technology Receives New FDA 510(k) Clearances and Bolsters Executive Management Team

Scott Lynch appointed Vice President of Global Marketing and Michael Scott Vice President of International.

Providence Medical Technology Appoints Gregory Curhan Chief Financial Officer

Mr. Curhan brings extensive experience managing high-performing teams and executing acquisition and public offering transactions.

1 2 3
Team | Innovation | Quality | Passion | Transparency
Copyright © 2022, Providence Medical Technology. All rights reserved.